No abstract available
Keywords:
Adverse events; Antibody response; BNT162b2 vaccine; Delayed second vaccine dose; Neutralizing antibody; RBD-binding IgG antibody; SARS-CoV-2 infection; mRNA vaccine.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Antibody Formation
-
BNT162 Vaccine*
-
COVID-19*
-
Humans
-
SARS-CoV-2
-
Vaccines, Synthetic
-
mRNA Vaccines
Substances
-
Vaccines, Synthetic
-
mRNA Vaccines
-
BNT162 Vaccine